Reply
- PMID: 36908027
- PMCID: PMC10804421
- DOI: 10.1002/art.42500
Reply
Conflict of interest statement
Conflicts of Interest
All authors declare that there are no conflicts of interest associated with this study.
Comment on
-
Association of dipeptidylpeptidase 4 (CD26) with chondrocyte senescence and radiographic progression in knee osteoarthritis: comment on the article by Chen et al.Arthritis Rheumatol. 2023 Sep;75(9):1678-1679. doi: 10.1002/art.42490. Epub 2023 Jul 3. Arthritis Rheumatol. 2023. PMID: 36897805 No abstract available.
References
-
- Mohetaer M, Li G, Wang Y, Cao L. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes. Biomedicine & Pharmacotherapy. 2018;104:590–4. - PubMed
-
- Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019;71(7):978–85. - PubMed
-
- Wang K, Chen X, Chen Y, Sheng S, Huang Z. Grape seed procyanidins suppress the apoptosis and senescence of chondrocytes and ameliorates osteoarthritis via the DPP4-Sirt1 pathway. Food & Function. 2020;11(12):10493–505. - PubMed
-
- Chen Z, Yu J, Fu M, Dong R, Yang Y, Luo J, et al. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. Biochemical pharmacology. 2020;177:113951. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
